Sobrato Capital

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on redefining psychiatry through the integration of patient neurobiology into the drug development process. Utilizing an AI-enabled biomarker platform, the company combines diverse information about patients' brain activity and behavior to create personalized and effective treatment options. Alto Neuroscience is developing several clinical assets, including ALTO-100, ALTO-202, ALTO-101, and ALTO-300, primarily targeting depressive disorders and schizophrenia, identified through independent brain-based biomarkers. By moving away from traditional trial-and-error methods, the company aims to align its innovative therapies with the specific needs of patients, ultimately improving the management of mental health conditions.

Komaza is a tech-driven sustainable forestry company founded in 2006 by Tevis Howard. It focuses on transforming the wood industry in Africa through its innovative farmer platform, which integrates technology, training, and services. By partnering with rural farmers to establish virtual plantations and plant woodlots, Komaza aims to create a sustainable wood supply while significantly reducing costs compared to traditional plantations. This approach not only addresses the growing demand for wood and wood products but also empowers small-holder farmers, enabling them to contribute to solving the wood supply crisis in the region.

Komaza is a tech-driven sustainable forestry company founded in 2006 by Tevis Howard. It focuses on transforming the wood industry in Africa through its innovative farmer platform, which integrates technology, training, and services. By partnering with rural farmers to establish virtual plantations and plant woodlots, Komaza aims to create a sustainable wood supply while significantly reducing costs compared to traditional plantations. This approach not only addresses the growing demand for wood and wood products but also empowers small-holder farmers, enabling them to contribute to solving the wood supply crisis in the region.

Decibel Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing innovative therapies aimed at protecting, repairing, and restoring hearing. The company addresses various hearing disorders, including those related to pediatric cancers, cystic fibrosis, noise exposure, age-related and genetic hearing loss, as well as conditions characterized by persistent tinnitus. Decibel Therapeutics employs a multifaceted approach that includes drug delivery to the inner ear, advanced imaging techniques, and pharmacokinetic and pharmacodynamic modeling. The company leverages its expertise in inner ear biology, single-cell genomics, and bioinformatics to develop effective treatments for hearing loss and related disorders. Established in 2013 and headquartered in Boston, Massachusetts, Decibel Therapeutics was originally known as Hearing, Inc. before rebranding in 2014.

Drexel Schools is a resource-rich, cutting-edge approach to Catholic education. Committed to redefining student engagement through robust technology and data-driven instruction, Drexel Schools is transforming Catholic education. Drexel Schools seeks to prove that the creation of a new model of Catholic schools is possible and scalable. The network of Drexel Schools forms the whole person through faith, knowledge, community, and by leveraging the resources and knowledge of a network of Catholic schools. Drexel Schools are recognized for sending forth into the greater community Christ-centered, compassionate, and confident leaders and problem solvers who exercise moral courage and service to others in their daily lives.

Kueski is a prominent buy now, pay later (BNPL) and online consumer lending company based in Mexico, established in 2012. Its primary mission is to enhance the financial lives of consumers in Mexico by providing easy access to financial services. Kueski operates through two main products: Kueski Pay, which facilitates BNPL transactions both online and in physical stores, and Kueski Cash, which offers personal loans. The company employs advanced technologies, including artificial intelligence and big data, to assess credit and fraud risk, allowing for swift approval or denial of loan applications within minutes. This innovative approach aims to meet short-term financial needs while integrating seamlessly with the Mexican economy. Kueski has successfully raised over $300 million in equity and debt financing and has garnered recognition within the industry, including a spot on CB Insights' Fintech 250 List.